UPS Acquires Bomi Group from ARCHIMED
December 16, 2021
UPS has agreed to acquire Italy-headquartered healthcare logistics provider Bomi Group from ARCHIMED's MED Platform I. ARCHIMED, which took Bomi private in 2019, will exit after helping internationalize and grow the business; Bomi's management and founding family will remain in place following the transaction.
- Buyers
- UPS
- Targets
- Bomi Group
- Sellers
- ARCHIMED, Bomi founding family and management
- Industry
- Logistics & Distribution
- Location
- Lombardy, Italy
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
ARCHIMED-backed BOMI Group Completes Six Add-on Acquisitions
January 25, 2021
Logistics & Distribution
Between May 2020 and January 2021, ARCHIMED-backed BOMI Group completed six buy-and-build acquisitions—Logifarma, Consigliere, Autotransporti Gigliotti & Bergamin, RH Logistics (UK), Deco Pharma (Spain) and Florence Shipping—adding roughly 20% to BOMI's annual revenues. The deals expand BOMI's geographic footprint into the UK and Iberia and broaden its healthcare logistics capabilities (including specialist air freight and clinical-trial sample handling).
-
Bomi Group Acquires Integrated Logistics Services (ILS) in Ecuador and Peru
August 14, 2019
Logistics & Distribution
Bomi Group has acquired 100% of the share capital of a group of five companies operating as Integrated Logistics Services (ILS) across Ecuador and Peru. The deal expands Bomi's presence in Latin America and strengthens its pharma and animal-health cold-chain, warehousing and distribution capabilities (ILS operates in Quito, Guayaquil, Cuenca and Lima and provides 45,000 sqm of warehousing, 1,500 m³ of cold rooms and a 120-truck fleet).
-
ARCHIMED Acquires BioVendor Group
March 11, 2025
Medical Devices
ARCHIMED, a Europe-focused private equity firm specializing in healthcare, has acquired BioVendor Group, a Brno-headquartered developer and manufacturer of in‑vitro diagnostics and immunoassays. ARCHIMED will partner with existing management to accelerate internationalization, product innovation and commercial expansion as part of its MED III fund's diagnostics investment strategy.
-
ARCHIMED Acquires Majority Stake in Cube (Cube Biotech)
November 3, 2021
Biotechnology
Transatlantic healthcare private equity firm ARCHIMED has purchased a majority stake in Monheim, Germany-based Cube (Cube Biotech), a specialist provider of high-purity, stable membrane proteins for drug discovery. ARCHIMED will support Cube's US market expansion and broaden its product and service offering organically and via acquisitions while Cube's founding management remain significant shareholders and continue to lead the business.
-
ARCHIMED Acquires FIM Medical
October 15, 2024
Medical Devices
ARCHIMED, a healthcare-focused private equity firm, has acquired FIM Medical, a Lyon-based leader in occupational health medical devices specializing in vision testers, audiometers and spirometers. The acquisition, executed by ARCHIMED's MED Rise fund, positions the firm to strengthen its neuro & sensory and occupational health capabilities and support FIM Medical's international expansion.
-
ARCHIMED Acquires and Merges Symbio and Proinnovera to Form Symbio Proinnovera
November 17, 2023
Healthcare Services
ARCHIMED has acquired US-based Symbio and Germany-based Proinnovera in an all-equity deal and merged them to create Symbio Proinnovera, a specialized dermatology-focused CRO. The combined group will offer end-to-end dermatology consulting, formulation, testing and clinical research across North America and Europe, with founders rolling equity into the new platform and ARCHIMED-appointed operating partners joining the board to drive growth and further acquisitions.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.